Graphene quantum dots show promise in targeting Parkinson's-related protein clumping

The accumulation of a protein called 𝛂-synuclein (ASN) into toxic clumps is a hallmark of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson’s disease and multiple system atrophy (MSA). These aggregates are associated with cellular dysfunction and lead to progressive neuronal loss. Since current treatments only treat symptoms rather than stopping the clumping of underlying proteins, scientists are exploring new strategies, including nanomaterials that can prevent these aggregates from forming or help clear them from the brain.